The Hemodynamic Effects of SGLT2i in Acute Decompensated Heart Failure

Summary

The main purpose of this study is to observe hemodynamic effects of initiating sodium-glucose co-transporter 2 inhibitors (SGLT2i) in patients admitted to the intensive care unit (ICU) with acute decompensated heart failure.

Timeline

Start

2023-05-22

Primary completion

2023-05-23

Completion

2023-05-23

Outcome

Outcome not reported

Stopped (Enrollment): “Enrollment goals were not met.”

Drugs

Indications